Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet Parasitol ; 328: 110154, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38490160

RESUMO

Previous vaccination trials have demonstrated that thiol proteins affinity purified from Ostertagia ostertagi excretory-secretory products (O. ostertagi ES-thiol) are protective against homologous challenge. Here we have shown that protection induced by this vaccine was consistent across four independent vaccine-challenge experiments. Protection is associated with reduced cumulative faecal egg counts across the duration of the trials, relative to control animals. To better understand the diversity of antigens in O. ostertagi ES-thiol we used high-resolution shotgun proteomics to identify 490 unique proteins in the vaccine preparation. The most numerous ES-thiol proteins, with 91 proteins identified, belong to the sperm-coating protein/Tpx/antigen 5/pathogenesis-related protein 1 (SCP/TAPS) family. This family includes previously identified O. ostertagi vaccine antigens O. ostertagi ASP-1 and ASP-2. The ES-thiol fraction also has numerous proteinases, representing three distinct classes, including: metallo-; aspartyl- and cysteine proteinases. In terms of number of family members, the M12 astacin-like metalloproteinases, with 33 proteins, are the most abundant proteinase family in O. ostertagi ES-thiol. The O. ostertagi ES-thiol proteome provides a comprehensive database of proteins present in this vaccine preparation and will guide future vaccine antigen discovery projects.


Assuntos
Antígenos de Helmintos , Ostertagia , Vacinas , Animais , Ostertagia/imunologia , Vacinas/imunologia , Antígenos de Helmintos/imunologia , Ostertagíase/veterinária , Ostertagíase/prevenção & controle , Ostertagíase/imunologia , Compostos de Sulfidrila , Fezes/parasitologia , Proteômica , Contagem de Ovos de Parasitas/veterinária
2.
Vet Immunol Immunopathol ; 268: 110705, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38157760

RESUMO

Receptor activator of nuclear factor Kappa-B Ligand (RANKL) is a member of the tumor necrosis factor ligand (TNF) family involved in immune responses and immunomodulation. Expressed in various cells types around the body, RANKL plays a crucial role in bone remodeling and development of the thymus, lymph nodes and mammary glands. Research in other species demonstrates that RANKL is required for the development of microfold cells (M cells) in the gut, however limited information specific to cattle is available. Cloning and expression of bovine RANKL (BoRANKL) was carried out and bioactivity of the protein was demonstrated in the induction of osteoclast differentiation from both bovine and ovine bone marrow cells. The effects of BoRANKL on particle uptake in bovine enteroids was also assessed. The production of cross-reactive bovine RANKL protein will enable further investigations into cell differentiation using the available ruminant organoid systems, and their role in investigating host-pathogen interactions in cattle and sheep.


Assuntos
NF-kappa B , Osteoclastos , Bovinos , Animais , Ovinos , NF-kappa B/metabolismo , Receptor Ativador de Fator Nuclear kappa-B/metabolismo , Receptor Ativador de Fator Nuclear kappa-B/farmacologia , Osteoclastos/metabolismo , Ligantes , Diferenciação Celular , Ligante RANK/metabolismo , Ligante RANK/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA